PROCEPT BioRobotics (PRCT) Operating Income Growth (3y) (2023 - 2026)
PROCEPT BioRobotics (PRCT) Operating Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 75.54% |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | -2.70% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn | 34.83% |
| 10 | PROCEPT BioRobotics | 1.02 Bn | 772.69 Mn | 53.95 Mn | -4.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.74% |
| Dec 31, 2025 | -7.42% |
| Sep 30, 2025 | -1.61% |
| Jun 30, 2025 | -7.47% |
| Mar 31, 2025 | -20.44% |
| Dec 31, 2024 | -5.40% |
| Sep 30, 2024 | -20.56% |
| Jun 30, 2024 | -26.69% |
| Mar 31, 2024 | -34.58% |
| Dec 31, 2023 | -30.80% |
| Sep 30, 2023 | -32.62% |